Found: 7
Select item for more details and to access through your institution.
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 802, doi. 10.1002/ajh.26529
- By:
- Publication type:
- Article
NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 23, p. 2748, doi. 10.3390/cells12232748
- By:
- Publication type:
- Article
Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone Disease.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 3, p. 448, doi. 10.3390/cells12030448
- By:
- Publication type:
- Article
Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 5, p. 967, doi. 10.3390/cells10050967
- By:
- Publication type:
- Article
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11470, doi. 10.3390/ijms222111470
- By:
- Publication type:
- Article
A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1333, doi. 10.3390/cancers12051333
- By:
- Publication type:
- Article
Natural Killer Cells in the Malignant Niche of Multiple Myeloma.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.816499
- By:
- Publication type:
- Article